SCHEMBL6245151

SCHEMBL6245151

COc1ccccc1CNc1ccc(-c2nn(C3CCNCC3)c3ccnc(N)c23)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 16/20 0.44
ERBB2 P04626 2/20 0.44
IGF1R P08069 2/20 0.44
FGFR1 P11362 1/20 0.44
BTK Q06187 6/20 0.41
SRC P12931 5/20 0.41
KDR P35968 4/20 0.41
PIK3CD O00329 3/20 0.41
ABL1 P00519 3/20 0.41
HCK P08631 3/20 0.41
PIK3CA P42336 3/20 0.41
PIK3CB P42338 3/20 0.41
MTOR P42345 3/20 0.41
PIK3CG P48736 3/20 0.41
EPHB4 P54760 3/20 0.41
PRKDC P78527 3/20 0.41
PI4KB Q9UBF8 3/20 0.41
MAP4K3 Q8IVH8 1/20 0.41
LCK P06239 1/20 0.40
TEK Q02763 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5812688 0.89 EGFR (0.44) EGFRERBB2IGF1RFGFR1BTK
SCHEMBL4826519 0.87 FGFR1 (0.59) EGFRERBB2IGF1RFGFR1BTK
SCHEMBL5819727 0.85 NTRK1 (0.44) EGFRBTKSRCKDRMAP4K3
SCHEMBL6247706 0.81 SRC (0.44) EGFRBTKSRCKDRPIK3CD
SCHEMBL5822805 0.79 SRC (0.40) EGFRFGFR1SRCKDRPIK3CD
SCHEMBL6248834 0.78 SRC (0.43) EGFRERBB2IGF1RFGFR1BTK
SCHEMBL4824869 0.78 EGFR (0.57) EGFRERBB2IGF1RFGFR1BTK
SCHEMBL5817387 0.78 LCK (0.46) EGFRBTKSRCKDRPIK3CD
SCHEMBL7112685 0.77 KDM4E (0.41) EGFRERBB2IGF1RBTKSRC
SCHEMBL6272921 0.77 EGFR (0.40) EGFRFGFR1BTKSRCKDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1379528-A4 PYRAZOLOPYRIMIDINES AS THERAPEUTIC AGENTS ABBOTT GMBH (DE) 2005-12-07 EP disclosed
WO-2004100868-A2 METHOD OF TREATING TRANSPLANT REJECTION ABBOTT LABORATORIES (US) 2004-11-25 WO disclosed
EP-1379528-A1 PYRAZOLOPYRIMIDINES AS THERAPEUTIC AGENTS ABBOTT GmbH (DE) 2004-01-14 EP disclosed
WO-2002076986-A1 PYRAZOLOPYRIMIDINES AS THERAPEUTIC AGENTS ABBOTT GMBH & CO. KG (DE) 2002-10-03 WO disclosed